| All-cause dementia | Alzheimer’s disease | Vascular dementia | ||||||
---|---|---|---|---|---|---|---|---|---|
 | Model 1 | Model 2 | Model 3 | Model 1 | Model 2 | Model 3 | Model 1 | Model 2 | Model 3 |
Uric acid ≤ 400 | |||||||||
 Non-MetS | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref |
 MetS | 1.22 (1.15–1.29)* | 1.07 (1.01–1.14)* | 1.03 (0.97–1.10) | 1.09 (1.00–1.20) | 0.99 (0.90–1.08) | 0.96 (0.88–1.06) | 1.57 (1.39–1.77)* | 1.34 (1.18–1.52)* | 1.23 (1.08–1.40)* |
Uric acid > 400 | |||||||||
 Non-MetS | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref |
 MetsS | 1.35 (1.21–1.49)* | 1.23 (1.11–1.37)* | 1.17 (1.05–1.30)* | 1.16 (0.98–1.37) | 1.09 (0.92–1.30) | 1.07 (0.89–1.27) | 1.77 (1.45–2.16)* | 1.56 (1.27–1.92)* | 1.39 (1.13–1.71)* |
Joint effect of MetS and uric acid | |||||||||
 Non-MetS SUA ≤ 400 | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref | Ref |
 Non-MetS SUA > 400 | 0.96 (0.89–1.04) | 0.95 (0.87–1.03) | 0.95 (0.87–1.02) | 0.94 (0.83–1.06) | 0.94 (0.83–1.06) | 0.94 (0.83–1.06) | 1.11 (0.94–1.31) | 1.09 (0.92–1.28) | 1.08 (0.91–1.27) |
 MetS SUA ≤ 400 | 1.22 (1.15–1.29)* | 1.07 (1.01–1.14)* | 1.03 (0.97–1.10) | 1.09 (1.00–1.20)* | 0.99 (0.90–1.08) | 0.96 (0.88–1.06) | 1.57 (1.39–1.77)* | 1.34 (1.18–1.52)* | 1.23 (1.08–1.40)* |
 MetS SUA > 400 | 1.29 (1.19–1.41)* | 1.17 (1.07–1.27)* | 1.11 (1.02–1.21)* | 1.10 (0.96–1.26) | 1.02 (0.88–1.17) | 0.98 (0.85–1.13) | 1.94 (1.66–2.28)* | 1.69 (1.44–1.99)* | 1.50 (1.28–1.77)* |